Back

Niagen Bioscience announces agreement for first-of-its-kind healthy aging clinical trial

Verifying
  • Niagen Bioscience announced a start-up agreement with Mass General Brigham investigators.
  • The agreement concerns a first-of-its-kind clinical trial focused on healthy aging.
  • Mass General Brigham investigators are involved in the trial’s start-up phase.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Niagen Bioscience announces agreement for first-of-its-kind healthy aging clinical trial - CoinPost Terminal